Literature DB >> 26053590

Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).

Samuel O Antwi1, Susan E Steck2,3, L Joseph Su4, James R Hébert2,3, Hongmei Zhang5, Elizabeth T H Fontham6, Gary J Smith7, Jeannette T Bensen8, James L Mohler7, Lenore Arab9.   

Abstract

BACKGROUND: Controversies remain over the safety and efficacy of vitamin E (i.e., α-tocopherol) supplementation use for the prevention of prostate cancer (CaP); however, associations of different tocopherol forms and CaP aggressiveness have yet to be examined.
METHODS: This study examined whether food intake of tocopherols, vitamin E supplement use, and adipose tissue biomarkers of tocopherol were associated with CaP aggressiveness among African-American (AA, n = 1,023) and European-American (EA, n = 1,079) men diagnosed with incident CaP. Dietary tocopherols were estimated from a food frequency questionnaire, supplement use from questionnaire/inventory, and biomarkers from abdominal adipose samples measured using high-performance liquid chromatography. Odds ratios (ORs) and 95% confidence intervals (95%CIs) were estimated from logistic regression comparing high-aggressive CaP to low/intermediate aggressive CaP, adjusting for covariates.
RESULTS: Dietary intakes of α-and δ-tocopherol were related inversely to CaP aggressiveness among EAs [OR (95%CI), highest versus lowest quartile: α-tocopherol, 0.34 (0.17-0.69), P(trend)  = 0.006; δ-tocopherol, 0.45 (0.21-0.95) P(trend)  = 0.007]. Inverse associations between dietary and supplemental α-tocopherol and CaP aggressiveness were observed among AAs, though these did not reach statistical significance [OR (95%CI), highest versus lowest quartile: dietary α-tocopherol, 0.58 (0.28-1.19), P(trend)  = 0.20; supplemental α-tocopherol, 0.64 (0.31-1.21) P(trend)  = 0.15]. No significant association was observed between adipose tocopherol levels and CaP aggressiveness [OR (95%CI), highest versus lowest quartiles of α-tocopherol for EAs 1.43 (0.66-3.11) and AAs 0.66 (0.27-1.62)].
CONCLUSIONS: The inverse associations observed between dietary sources of tocopherols and CaP aggressiveness suggests a beneficial role of food sources of these tocopherols in CaP aggressiveness.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  adipose tissue; diet; nutritional biomarkers; prostate cancer; supplement; tocopherols; vitamin E

Mesh:

Substances:

Year:  2015        PMID: 26053590      PMCID: PMC5072779          DOI: 10.1002/pros.23025

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  58 in total

Review 1.  The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis.

Authors:  Julie Stratton; Marshall Godwin
Journal:  Fam Pract       Date:  2011-01-27       Impact factor: 2.267

2.  Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.

Authors:  Rui Gao; Douglas K Price; Tristan Sissung; Eddie Reed; William D Figg
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

Review 3.  Role of diet in prostate cancer development and progression.

Authors:  June M Chan; Peter H Gann; Edward L Giovannucci
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

Review 4.  gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.

Authors:  Q Jiang; S Christen; M K Shigenaga; B N Ames
Journal:  Am J Clin Nutr       Date:  2001-12       Impact factor: 7.045

Review 5.  Dietary antioxidants and prostate cancer: a review.

Authors:  Terrence M Vance; Joseph Su; Elizabeth T H Fontham; Sung I Koo; Ock K Chun
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

6.  Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Kathryn B Arnold; Marian L Neuhouser; Phyllis Goodman; Elizabeth A Platz; Demetrius Albanes; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2010-08-06       Impact factor: 4.897

7.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

Authors:  Anthony V D'Amico; Judd Moul; Peter R Carroll; Leon Sun; Deborah Lubeck; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

8.  Associations of antioxidant nutrients and oxidative DNA damage in healthy African-American and White adults.

Authors:  Joanne L Watters; Jessie A Satia; Larry L Kupper; James A Swenberg; Jane C Schroeder; Boyd R Switzer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

9.  Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.

Authors:  J Michael Gaziano; Robert J Glynn; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Howard D Sesso; Julie E Buring
Journal:  JAMA       Date:  2008-12-09       Impact factor: 56.272

10.  A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Authors:  Ali Amin Al Olama; Zsofia Kote-Jarai; Fredrick R Schumacher; Fredrik Wiklund; Sonja I Berndt; Sara Benlloch; Graham G Giles; Gianluca Severi; David E Neal; Freddie C Hamdy; Jenny L Donovan; David J Hunter; Brian E Henderson; Michael J Thun; Michael Gaziano; Edward L Giovannucci; Afshan Siddiq; Ruth C Travis; David G Cox; Federico Canzian; Elio Riboli; Timothy J Key; Gerald Andriole; Demetrius Albanes; Richard B Hayes; Johanna Schleutker; Anssi Auvinen; Teuvo L J Tammela; Maren Weischer; Janet L Stanford; Elaine A Ostrander; Cezary Cybulski; Jan Lubinski; Stephen N Thibodeau; Daniel J Schaid; Karina D Sorensen; Jyotsna Batra; Judith A Clements; Suzanne Chambers; Joanne Aitken; Robert A Gardiner; Christiane Maier; Walther Vogel; Thilo Dörk; Hermann Brenner; Tomonori Habuchi; Sue Ingles; Esther M John; Joanne L Dickinson; Lisa Cannon-Albright; Manuel R Teixeira; Radka Kaneva; Hong-Wei Zhang; Yong-Jie Lu; Jong Y Park; Kathleen A Cooney; Kenneth R Muir; Daniel A Leongamornlert; Edward Saunders; Malgorzata Tymrakiewicz; Nadiya Mahmud; Michelle Guy; Koveela Govindasami; Lynne T O'Brien; Rosemary A Wilkinson; Amanda L Hall; Emma J Sawyer; Tokhir Dadaev; Jonathan Morrison; David P Dearnaley; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Nicholas Van As; Christopher J Woodhouse; Alan Thompson; Tim Dudderidge; Chris Ogden; Colin S Cooper; Artitaya Lophatonanon; Melissa C Southey; John L Hopper; Dallas English; Jarmo Virtamo; Loic Le Marchand; Daniele Campa; Rudolf Kaaks; Sara Lindstrom; W Ryan Diver; Susan Gapstur; Meredith Yeager; Angela Cox; Mariana C Stern; Roman Corral; Markus Aly; William Isaacs; Jan Adolfsson; Jianfeng Xu; S Lilly Zheng; Tiina Wahlfors; Kimmo Taari; Paula Kujala; Peter Klarskov; Børge G Nordestgaard; M Andreas Røder; Ruth Frikke-Schmidt; Stig E Bojesen; Liesel M FitzGerald; Suzanne Kolb; Erika M Kwon; Danielle M Karyadi; Torben Falck Orntoft; Michael Borre; Antje Rinckleb; Manuel Luedeke; Kathleen Herkommer; Andreas Meyer; Jürgen Serth; James R Marthick; Briony Patterson; Dominika Wokolorczyk; Amanda Spurdle; Felicity Lose; Shannon K McDonnell; Amit D Joshi; Ahva Shahabi; Pedro Pinto; Joana Santos; Ana Ray; Thomas A Sellers; Hui-Yi Lin; Robert A Stephenson; Craig Teerlink; Heiko Muller; Dietrich Rothenbacher; Norihiko Tsuchiya; Shintaro Narita; Guang-Wen Cao; Chavdar Slavov; Vanio Mitev; Stephen Chanock; Henrik Gronberg; Christopher A Haiman; Peter Kraft; Douglas F Easton; Rosalind A Eeles
Journal:  Hum Mol Genet       Date:  2012-10-12       Impact factor: 6.150

View more
  4 in total

Review 1.  Tocopherols in cancer: An update.

Authors:  Soumyasri Das Gupta; Nanjoo Suh
Journal:  Mol Nutr Food Res       Date:  2016-02-02       Impact factor: 5.914

Review 2.  Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols.

Authors:  Chung S Yang; Philip Luo; Zishuo Zeng; Hong Wang; Mokenge Malafa; Nanjoo Suh
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

3.  Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture.

Authors:  Susan Goodin; Isaac Kim; Mao-Jung Lee; Weichung J Shih; Michelle Orlick; Xi Zheng; Chung S Yang
Journal:  Nutr Cancer       Date:  2020-12-15       Impact factor: 2.900

Review 4.  Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations.

Authors:  Dominique Reed; Komal Raina; Rajesh Agarwal
Journal:  NPJ Precis Oncol       Date:  2018-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.